HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$0.13
−8.86%Institutional positioning
13F filings over the trailing two quarters
New 3Increased 2Reduced 3Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| StoneX Group Inc. | Increased | 102,310 | Aug 12, 2026 |
| JANE STREET GROUP, LLC | New Position | 49,087 | Aug 14, 2026 |
| HRT FINANCIAL LP | New Position | 41,824 | Aug 14, 2026 |
| STONEX GROUP INC. | Reduced | 39,395 | May 14, 2026 |
| XTX Topco Ltd | New Position | 38,930 | Aug 14, 2026 |
| CLEAR STREET GROUP INC. | Unchanged | 12,019 | May 15, 2026 |
| Clear Street Group Inc. | Unchanged | 12,019 | Aug 12, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 10,832 | May 15, 2026 |
| UBS Group AG | Increased | 1,081 | Aug 13, 2026 |
| UBS GROUP AG | Reduced | 110 | May 5, 2026 |
| TWO SIGMA INVESTMENTS, LP | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings